Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar with Gemcitabine-Carboplatin in NSCLC
NCT01549093Phase 2Unknown
- Sponsor
- Hunan Cancer Hospital
- Start
- Aug 2011
- Primary completion
- Jul 2016
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of endostar in non-small cell lung cancer (NSCLC), sponsored by Hunan Cancer Hospital. Status: unknown.
02
Drugs
endostar
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01549093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01549093.